AstraZeneca's Ultomiris Poised for Accelerated Approval in IgA Nephropathy After Striking Trial Results
A New Frontier in Breast Cancer: Enhertu Unveils Remarkable Promise for Early-Stage HER2-Low Patients
FDA Approves Tezspire Self-Administration, Revolutionizing Severe Asthma Care for Amgen and AstraZeneca
A New Horizon for Breast Cancer: Enhertu Shows Groundbreaking Survival Benefit in HER2-low Metastatic Patients
AstraZeneca Unveils Baxdrostat: The 'Miracle Drug' Poised to Revolutionize High Blood Pressure Treatment